• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Hey DT













Lol now that's funny. What is his Onc experience? He went to Walmart Onc training?

DT grossly exaggerates his oncology experience while at S/A…and was a failure with the Ligand products, so badly in fact that the company resorted to yet another loser in OB…it’s just a bad company with untalented people…but that’s what happens when you are a bottom of the barrel company…
 




DT grossly exaggerates his oncology experience while at S/A…and was a failure with the Ligand products, so badly in fact that the company resorted to yet another loser in OB…it’s just a bad company with untalented people…but that’s what happens when you are a bottom of the barrel company…

Unfortunately I agree and feel trapped and stuck here. :( recruiters laugh at us.
 




Unfortunately I agree and feel trapped and stuck here. :( recruiters laugh at us.

yup it's a sad state of affairs in Eisai oncology. Our best chances are getting over to a good big pharma oncology company since no tenured reps want those jobs as they go to the good bio's like Ariad, Pharmacyclics, Onyx, Medivation, SeaGen, Regeneron, Incyte, etc...nope we are stuck here or maybe get to an established big pharma oncology company...at least the good big pharmas have somewhat of a clue about oncology...we are just guessing here and pretending that the failed PC strategies will somehow miraculously work in oncology because after all pharmaceutical sales is pharmaceuticals...Right OB?